BRILL PHARMA is committed to the research and development
of new therapies that contribute to improving the quality of life of people.
R & D PROJECTS IN PROGRESS
BRILL PHARMA is researching in Spain, ongoing projects:
The damage to the cells of the retina by the wavelengths of blue light, which is the one emitted by most LED screens, is increasingly demonstrated.
BRILL PHARMA has underway the development of an eye drop to protect the cells of the retina from the LED light.
Traditional anti-inflammatory drugs have undesirable effects on the eye when used in the long term, BRILL PHARMA investigates a new category of eye anti-inflammatory drugs that allow their long-term use.